CVE-2021-25921

Description

In OpenEMR, versions 2.7.3-rc1 to 6.0.0 are vulnerable to Stored Cross-Site-Scripting (XSS) due to user input not being validated properly in the `Allergies` section. An attacker could lure an admin to enter a malicious payload and by that initiate the exploit.

Category

5.4
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 57.07% Top 5%
Third-Party Advisory github.com Third-Party Advisory whitesourcesoftware.com
Affected: n/a openemr
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2021-25921?
CVE-2021-25921 has been scored as a medium severity vulnerability.
How to fix CVE-2021-25921?
To fix CVE-2021-25921, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-25921 being actively exploited in the wild?
It is possible that CVE-2021-25921 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~57% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2021-25921?
CVE-2021-25921 affects n/a openemr.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.